What is the initial workup and management for a patient suspected of having sickle cell disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Workup and Management for Suspected Sickle Cell Disease

The initial workup for a patient suspected of having sickle cell disease should include hemoglobin electrophoresis as the definitive diagnostic test, along with a complete blood count, reticulocyte count, and comprehensive metabolic panel to assess baseline organ function. 1, 2

Diagnostic Testing

Primary Diagnostic Tests

  • Hemoglobin electrophoresis: Gold standard for diagnosis
    • Must be confirmed by a second test such as solubility test or electrophoresis on agar in citrate buffer 2
    • Isoelectrofocusing provides better resolution than conventional cellulose acetate electrophoresis
    • Some labs may use cation exchange HPLC as first-line test

Additional Laboratory Testing

  • Complete blood count (CBC): To assess baseline hemoglobin (typically 7-11 g/dL in steady state) 3
  • Reticulocyte count: Often elevated due to chronic hemolysis
  • Comprehensive metabolic panel: To evaluate renal and liver function
  • Lactate dehydrogenase (LDH) and bilirubin: Markers of hemolysis
  • Baseline oxygen saturation measurement 4

Specialized Testing (Based on Age and Presentation)

  • Children <16 years: Transcranial Doppler assessment to evaluate stroke risk 4
  • Adults with symptoms of pulmonary hypertension (SpO2 <94%, reduced exercise capacity): Consider echocardiogram 4

Initial Management

First-Line Therapy

  • Hydroxyurea: First-line disease-modifying therapy for most patients with SCD 1
    • Increases fetal hemoglobin and reduces red blood cell sickling
    • Should be initiated after consultation with hematology

Supportive Care

  • Hydration: Maintain adequate hydration to prevent sickling
  • Pain management: Develop individualized pain protocol based on severity
  • Infection prevention: Antibiotic prophylaxis as indicated

Additional Therapies

  • L-glutamine: FDA-approved adjunctive therapy
    • Reduces hospitalization rates by 33% and mean length of stay from 11 to 7 days compared to placebo 1
    • Dosing based on body weight:
      • <30 kg: 5g twice daily
      • 30-65 kg: 10g twice daily
      • 65 kg: 15g twice daily 5

Management of Acute Complications

Acute Pain Crisis

  • Aggressive hydration
  • Appropriate analgesia
  • Oxygen therapy if hypoxic
  • Blood transfusion not routinely indicated for uncomplicated pain crisis 3

Indications for Blood Transfusion

  • Acute hemolytic crisis
  • Aplastic crisis
  • Splenic sequestration
  • Acute chest syndrome
  • Stroke or high risk of stroke
  • Perioperative management 3

Transfusion Considerations

  • Blood should be HbS negative, Rh and Kell antigen matched 3
  • Document transfusion history to avoid complications
  • Monitor for hyperhemolysis syndrome, particularly in patients with recent transfusions 6

Multidisciplinary Care

  • Establish care with hematology specialist
  • Regular monitoring for disease complications:
    • Nephropathy
    • Retinopathy
    • Avascular necrosis
    • Priapism
    • Leg ulcers 1

Common Pitfalls to Avoid

  • Failure to recognize hyperhemolysis syndrome: Always ask about recent transfusions in patients with SCD presenting with acute symptoms 6
  • Inadequate pain management: SCD patients are not more likely to develop addiction to pain medications than the general population 1
  • Delayed diagnosis: In areas without newborn screening, maintain high index of suspicion in patients with unexplained severe atraumatic pain or normocytic anemia 1
  • Inadequate perioperative management: Patients with SCD require special perioperative considerations including hydration, temperature regulation, and possible transfusion 4

By following this systematic approach to diagnosis and management, patients with suspected sickle cell disease can receive timely and appropriate care to minimize complications and improve quality of life.

References

Research

[Sickle cell disease: laboratory and hemoglobin study].

Bulletin de la Societe de pathologie exotique (1990), 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hyperhemolysis Syndrome in a Patient with Sickle Cell Disease: A Case Report.

Clinical practice and cases in emergency medicine, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.